Rapid and sensitive electrochemical point-of-care testing for the chemotherapy agent cisplatin via Co-catalyzed hydrolysis of a glucose derivative
Biosensors and Bioelectronics · 2027-02 · 317 · 119341
DOI: 10.1016/j.bios.2026.119341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027-02. Verfasst von Lingying Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biliary Surgical Department of West China Hospital, Sichuan University, Chengdu, Sichuan, 610064, PR China; Research Center for Biliary Diseases, Wes…. Hauptthemen laut MEDLINE: Cisplatin, Antineoplastic Agents, Biosensing Techniques, Glucose. Die Arbeit nennt 34 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
In this work, we report a rapid, sensitive, and portable assay of cisplatin (DDP) related to cancer chemotherapy based on co-catalyzed hydrolysis of a glucose derivative with a portable glucose meter (PGM) for signal readout, which squarely challenges the expensive and time-consuming drawbacks of traditional detection methods such as inductively-coupled plasma mass spectrometry (ICP-MS) and atomic absorption spectrometry. Impressively, the target DDP could efficiently catalyze the hydrolysis of a newly synthesized glucose derivative (6-O-(Benzothiazol-2-yl)-β-D-glucopyranose, GD) with use of Hg2+ as a co-catalyst for rapidly releasing glucose as a mimic target to significantly increase electrochemical signal response, which is sensitively quantified by a commercial PGM, achieving a linear range of 1 -100 μM and a detection limit for DDP as low as 1 μM, two orders of magnitude lower than that of conventional PGM-based glucose detection. Furthermore, the proposed assay was applied to detect DDP in 15 whole blood samples from clinical cancer patients undergoing chemotherapy, and the results showed good consistency with those obtained by the standard method (ICP-MS). This strategy provides a rapid, sensitive, and low-cost point-of-care testing (POCT) approach for platinum-based chemotherapeutic drugs, bridging the gap between laboratory-grade analysis and bedside monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biliary Surgical Department of West China Hospital, Sichuan University, Chengdu, Sichuan, 610064, PR China; Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR Chi…
- Southwest Medical University, Luzhou, 646000, Sichuan, PR China.
- Key Laboratory of Luminescent and Real-Time Analytical Chemistry (Southwest University), Ministry of Education, College of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715, PR China.
Zitieren
APA
Xia, L., Zhang, J., Hu, X., Cheng, N., Yuan, R., & Zhou, R. (2027). Rapid and sensitive electrochemical point-of-care testing for the chemotherapy agent cisplatin via Co-catalyzed hydrolysis of a glucose derivative. Biosensors and Bioelectronics, 317, 119341. https://doi.org/10.1016/j.bios.2026.119341
Vancouver
Xia L, Zhang J, Hu X, Cheng N, Yuan R, Zhou R. Rapid and sensitive electrochemical point-of-care testing for the chemotherapy agent cisplatin via Co-catalyzed hydrolysis of a glucose derivative. Biosensors and Bioelectronics. 2027;317:119341. doi:10.1016/j.bios.2026.119341
BibTeX
@article{Xia2027,
author = {Xia, Lingying and Zhang, Jie and Hu, Xingyu and Cheng, Nansheng and Yuan, Ruo and Zhou, Rongxing},
title = {Rapid and sensitive electrochemical point-of-care testing for the chemotherapy agent cisplatin via Co-catalyzed hydrolysis of a glucose derivative},
journal = {Biosensors and Bioelectronics},
year = {2027},
volume = {317},
pages = {119341},
doi = {10.1016/j.bios.2026.119341}
}
EUVIMED